USFDA said on Thursday said they approved a treatment for blood loss during and after surgery made by Germany's Fresenius
The Food and Drug Administration said it cleared the treatment, an intravenous solution called Voluven to prevent and treat a dangerous loss of blood volume during and after surgery.
The treatment is a man-made starch that expands blood plasma volume. The most common side effects were nausea and itching, the FDA said.
In a study, it proved as safe and effective as a drug made by B. Braun Medical Inc, called Hespan, when used during orthopedic surgery, the regulatory agency said.
The Food and Drug Administration said it cleared the treatment, an intravenous solution called Voluven to prevent and treat a dangerous loss of blood volume during and after surgery.
The treatment is a man-made starch that expands blood plasma volume. The most common side effects were nausea and itching, the FDA said.
In a study, it proved as safe and effective as a drug made by B. Braun Medical Inc, called Hespan, when used during orthopedic surgery, the regulatory agency said.
No comments:
Post a Comment